Your browser doesn't support javascript.
loading
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.
Ghorani, Ehsan; Quartagno, Matteo; Blackhall, Fiona; Gilbert, Duncan C; O'Brien, Mary; Ottensmeier, Christian; Pizzo, Elena; Spicer, James; Williams, Alex; Badman, Philip; Parmar, Mahesh K B; Seckl, Michael J.
Afiliación
  • Ghorani E; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London, UK.
  • Quartagno M; Institute for Clinical Trials and Methodology, University College London, London, UK.
  • Blackhall F; Christie National Health Service Foundation Trust, Manchester, UK.
  • Gilbert DC; Institute for Clinical Trials and Methodology, University College London, London, UK.
  • O'Brien M; Royal Marsden Hospital, Imperial College London, London, UK.
  • Ottensmeier C; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, UK.
  • Pizzo E; Department of Applied Health Research, University College London, London, UK.
  • Spicer J; King's College London, Guy's Hospital, London, UK.
  • Williams A; Imperial College Trials Unit-Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Badman P; Imperial College Trials Unit-Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Parmar MKB; Institute for Clinical Trials and Methodology, University College London, London, UK. Electronic address: m.parmar@ucl.ac.uk.
  • Seckl MJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London, UK. Electronic address: m.seckl@imperial.ac.uk.
Lancet Oncol ; 24(5): e219-e227, 2023 05.
Article en En | MEDLINE | ID: mdl-37142383

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...